v3.26.1
Revenue (Details) - EUR (€)
€ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenue      
Revenue from contracts with customers € 777,079 € 782,517 € 772,009
Revenue from contributions 11,294 14,450 9,417
Total revenue 788,373 796,967 781,426
At a point in time      
Revenue      
Revenue from contracts with customers 164,152 127,280 88,587
Over a period of time      
Revenue      
Revenue from contracts with customers 612,927 655,237 683,421
Fee for service and FTE-based research services      
Revenue      
Revenue from contracts with customers 612,927 737,394 726,929
Material re-charges to customers      
Revenue      
Revenue from contracts with customers 31,892 38,578 37,561
Milestone fees      
Revenue      
Revenue from contracts with customers 9,615 2,871 4,785
Licences      
Revenue      
Revenue from contracts with customers 122,345 3,130 675
Other fees      
Revenue      
Revenue from contracts with customers 300 544 2,059
Discovery & Preclinical Development      
Revenue      
Revenue from contracts with customers 517,636 599,086 664,516
Revenue from contributions 11,294 12,308 8,461
Total revenue 528,930 611,394 672,977
Discovery & Preclinical Development | At a point in time      
Revenue      
Revenue from contracts with customers 49,121 83,157 42,345
Discovery & Preclinical Development | Over a period of time      
Revenue      
Revenue from contracts with customers 468,515 515,929 622,171
Discovery & Preclinical Development | Fee for service and FTE-based research services      
Revenue      
Revenue from contracts with customers 468,515 553,963 619,437
Discovery & Preclinical Development | Material re-charges to customers      
Revenue      
Revenue from contracts with customers 31,892 38,578 37,561
Discovery & Preclinical Development | Milestone fees      
Revenue      
Revenue from contracts with customers 9,615 2,871 4,785
Discovery & Preclinical Development | Licences      
Revenue      
Revenue from contracts with customers 7,314 3,130 674
Discovery & Preclinical Development | Other fees      
Revenue      
Revenue from contracts with customers 300 544 2,059
Just - Evotec Biologics      
Revenue      
Revenue from contracts with customers 259,443 183,431 107,493
Revenue from contributions   2,142 956
Total revenue 259,443 185,573 108,449
Just - Evotec Biologics | At a point in time      
Revenue      
Revenue from contracts with customers 115,031 44,123 46,242
Just - Evotec Biologics | Over a period of time      
Revenue      
Revenue from contracts with customers 144,412 139,308 61,251
Just - Evotec Biologics | Fee for service and FTE-based research services      
Revenue      
Revenue from contracts with customers 144,412 € 183,431 107,492
Just - Evotec Biologics | Licences      
Revenue      
Revenue from contracts with customers € 115,031   € 1